The leading funder of multiple myeloma research
As the leading funder of multiple myeloma research, the MMRF has supported more than 380 research grants at over 135 institutions worldwide. The MMRF supports innovative research efforts in the most promising areas of multiple myeloma research through several grant-making programs.
We remain committed to supporting researchers who have more than five years experience in blood cancer research as well as attracting younger scientists to enter the myeloma research field to build the next generation of scientific leaders.
The MMRF welcomes proposals on any and all multiple myeloma related topics to the traditional Research Grant Award programs and from biotech companies with investigational agents for multiple myeloma. For traditional research grants, applications are accepted from non-profit institutions and universities in the United States and internationally. Program guidelines and applications are available approximately 6-8 weeks prior to the submission deadline.
Research Fellow Awards:
The Multiple Myeloma Research Foundation (MMRF) seeks proposals for the MMRF 2022 Research Fellow Award Program, an initiative supporting researchers at the post-doctorate, medical fellow or junior faculty levels working under the supervision or guidance of a research mentor in the multiple myeloma field. Applications for the MMRF 2022 Research Fellow Award Program are due Friday, June 24th, 2022. The goal of this initiative is to engage and support young investigators entering the field of multiple myeloma while advancing the understanding of myeloma disease biology and disease risk, treatment and response and drug resistance. Proposals may request up to $150,000 over two (2) years.
MMRF Research Fellow Award Program Fosters Next Generation of Myeloma Researchers
The Multiple Myeloma Research Foundation has named the recipients of the 2021 MMRF Research Fellow Award Program. This program aims to prepare and support the next generation of young investigators who are at the forefront of research into myeloma disease biology, patient response to treatment and drug resistance and the advancement of precision medicine in the field of myeloma.
The 2021 Research Fellow Award Winners are:
Francesca Cottini, MD
The role of CD56 signaling in escaping from
immune surveillance of NK cells
Praneeth Sudalagunta, PhD
A Multiomic Approach to Reversing Therapy Resistance in Multiple Myeloma
Travis Johnson, PhD
Deep learning-based identification of progression-associated myeloma cells